Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Novel Molecular Targets in experimental Joubert Syndrome via Longitudinal Ahi1 Transcriptomics
FY 2025-26
Summary
Joubert syndrome (JS) is a rare neurodevelopmental disease that often affects multiple organ systems, however the biological mechanisms underlying its impact on the kidneys remain largely unexplored. JS belongs to a group of diseases called renal ciliopathies, which includes the more common autosomal dominant polycystic kidney disease. These diseases share similar disease presentation and underlying mechanisms. Ciliopathies affect structures called cilia, cell surface sensory organelles found on the cells lining tubules in the kidney. These tiny hair-like structures detect fluid flow and trigger appropriate responses through a variety of signalling pathways, influencing processes including tissue repair and gene expression.
JS can be caused by mutations in over 30 cilia-associated genes. Around 30% of patients with JS experience kidney disease, typically in those with pathogenic variants in the genes AHI1, CEP290 and TMEM67. The proposed research is guided by the hypothesis that characterizing changes in gene expression and regulation in the kidneys of mice lacking expression of the Ahi1 gene (Ahi-/-) will reveal biological pathways that can be explored for therapeutic development. The aims are to, in Ahi-/- mice, 1) Describe the renal phenotype including ciliary, structural, and functional changes, and 2) Identify and quantify gene expression differences by defining the renal RNA signature. Results will be compared to controls across both sexes at 10 days, 2.5, 5, and 12 months of age.
Systematic investigation of kidney disease in JS, leveraging state-of-the-art technologies, holds substantial potential to generate novel mechanistic insights with broad relevance across ciliopathies and to inform the development of new diagnostic and therapeutic strategies.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573050
Name
Turner Jamie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Novel Molecular Targets in experimental Joubert Syndrome via Longitudinal Ahi1 Transcriptomics
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Ciliopathy; Joubert Syndrome; Kidney; Transcriptome
Abstract
Joubert syndrome (JS) is a rare neurodevelopmental disease that often affects multiple organ systems, however the biological mechanisms underlying its impact on the kidneys remain largely unexplored. JS belongs to a group of diseases called renal ciliopathies, which includes the more common autosomal dominant polycystic kidney disease. These diseases share similar disease presentation and underlying mechanisms. Ciliopathies affect structures called cilia, cell surface sensory organelles found on the cells lining tubules in the kidney. These tiny hair-like structures detect fluid flow and trigger appropriate responses through a variety of signalling pathways, influencing processes including tissue repair and gene expression.
JS can be caused by mutations in over 30 cilia-associated genes. Around 30% of patients with JS experience kidney disease, typically in those with pathogenic variants in the genes AHI1, CEP290 and TMEM67. The proposed research is guided by the hypothesis that characterizing changes in gene expression and regulation in the kidneys of mice lacking expression of the Ahi1 gene (Ahi-/-) will reveal biological pathways that can be explored for therapeutic development. The aims are to, in Ahi-/- mice, 1) Describe the renal phenotype including ciliary, structural, and functional changes, and 2) Identify and quantify gene expression differences by defining the renal RNA signature. Results will be compared to controls across both sexes at 10 days, 2.5, 5, and 12 months of age.
Systematic investigation of kidney disease in JS, leveraging state-of-the-art technologies, holds substantial potential to generate novel mechanistic insights with broad relevance across ciliopathies and to inform the development of new diagnostic and therapeutic strategies.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Turner, Jamie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~